Institute of Biomedicine and Translational Medicine, Department of Physiology, University of Tartu, Tartu, Estonia; Centre of Excellence for Genomics and Translational Medicine, University of Tartu, Tartu, Estonia.
Institute of Biomedicine and Translational Medicine, Department of Physiology, University of Tartu, Tartu, Estonia; Centre of Excellence for Genomics and Translational Medicine, University of Tartu, Tartu, Estonia.
Free Radic Biol Med. 2023 Nov 1;208:1-12. doi: 10.1016/j.freeradbiomed.2023.07.029. Epub 2023 Jul 26.
Heritable renal cancer syndromes (RCS) are associated with numerous chromosomal alterations including inactivating mutations in von Hippel-Lindau (VHL) gene. Here we identify a novel aspect of the phenotype in VHL-deficient human renal cells. We call it reductive stress as it is characterised by increased NADH/NAD ratio that is associated with impaired cellular respiration, impaired CAC activity, upregulation of reductive carboxylation of glutamine and accumulation of lipid droplets in VHL-deficient cells. Reductive stress was mitigated by glucose depletion and supplementation with pyruvate or resazurin, a redox-reactive agent. This study demonstrates for the first time that reductive stress is a part of the phenotype associated with VHL-deficiency in renal cells and indicates that the reversal of reductive stress can augment respiratory activity and CAC activity, suggesting a strategy for altering the metabolic profile of VHL-deficient tumours.
遗传性肾癌综合征(RCS)与许多染色体改变有关,包括抑癌基因 von Hippel-Lindau(VHL)的失活突变。在这里,我们在 VHL 缺陷的人类肾细胞中发现了该表型的一个新方面。我们称之为还原应激,因为它的特点是 NADH/NAD 比值增加,这与细胞呼吸受损、CAC 活性受损、谷氨酰胺的还原羧化上调以及 VHL 缺陷细胞中脂滴积累有关。还原应激可通过葡萄糖耗竭和补充丙酮酸或还原型黄素二核苷酸(resazurin)来缓解,resazurin 是一种氧化还原反应性试剂。这项研究首次表明,还原应激是与肾细胞中 VHL 缺陷相关表型的一部分,并表明还原应激的逆转可以增强呼吸活性和 CAC 活性,这表明改变 VHL 缺陷肿瘤代谢特征的一种策略。